Global Sexually Transmitted Disease (STD) Self-Testing Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Sexually Transmitted Disease (STD) Self-Testing Market Be Worth By 2029?
The market size for self-testing of sexually transmitted diseases (STDs) has seen a significant increase in the recent past. From $1.38 billion in the year 2024, it is projected to reach $1.52 billion in the subsequent year, 2025, at a compound annual growth rate (CAGR) of 10.1%. The growth during the historic period can be attributed to an enhanced understanding of sexual health, an uptick in the adoption of healthcare solutions that can be utilized at home, an increase in government-sponsored STD screening initiatives, more availability of self-test kits that can be bought over-the-counter, and escalating concerns pertaining to privacy during testing in clinics.
The market size for self-testing of sexually transmitted diseases (STDs) is forecasted to experience notable growth in the near future, expanding to $2.21 billion by 2029 with a compound annual growth rate (CAGR) of 9.8%. The reasons for this growth in the predicted period include an uptick in sexual infection cases, a growing demand for private and convenient testing methods, more integration of digital health in self-testing kits, wider access to home diagnostic tests in developing markets, and regulatory bodies’ increasing approval of sophisticated self-testing techniques. Key trends anticipated in this forecast period encompass progress in speedy molecular diagnostic technologies, enhancements in mobile app integration for results monitoring, creation of self-testing kits for multiple infections, innovations in discreet delivery and packaging models, and advancements in AI-driven interpretation of test outcomes.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
Which Key Factors Are Fueling Growth In The Sexually Transmitted Disease (STD) Self-Testing Market?
The escalating prevalence of syphilis is anticipated to drive the expansion of the sexually transmitted disease (STD) self-testing market. Syphilis, a sexually transmitted infection, leads to sores on the body and may result in substantial health issues if not addressed. The surge in Syphilis cases is due to the decrease in regular condom use, especially among groups involved in risky sexual practices. STD self-testing provides a confidential and convenient way to screen for syphilis at home, encouraging early detection. Timely detection guarantees swift treatment, reducing complications, and preventing additional spread. For example, about 209,253 syphilis cases were documented in 2023 as stated by the Centers for Disease Control and Prevention, a US government agency. This signifies a 1% growth from 207,269 cases in 2022. Consequently, the escalating prevalence of syphilis is steering the expansion of the sexually transmitted disease (STD) self-testing market.
Which Segmentation Factors Are Critical In The Sexually Transmitted Disease (STD) Self-Testing Market Analysis?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
What Are The Dominant Trends Currently Seen In The Sexually Transmitted Disease (STD) Self-Testing Market?
Leading corporations in the STD self-testing market are emphasizing on the development of advanced products such as over-the-counter (OTC) sample collection kits. These kits aim at fostering early detection and immediate treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic instruments that allow people to collect samples like urine or swabs without a prescription. They offer a private and convenient way to identify infections early and initiate quick treatment. For example, in August 2023, a US digital health firm named iHealth Labs Inc. introduced the CheckMeSafe home collection kit designed for HIV and syphilis testing. This FDA-approved kit is available for individuals 18 years and older, enabling them to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing at home. Users can then send their samples back to the lab using a prepaid overnight label, with the expectation to receive secure, trustworthy results within two days. The kit possesses a high degree of accuracy, showcasing sensitivity rates reaching up to 99.9% and 99.5% for HIV and syphilis respectively. All samples undergo examination in a CLIA-certified and CAP-accredited lab, ensuring they meet strict federal and state quality standards through frequent inspections.
Which Players Are Shaping The Competitive Landscape Of The Sexually Transmitted Disease (STD) Self-Testing Market?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Sexually Transmitted Disease (STD) Self-Testing Market?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2025, By The Business Research Company
Self Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/self-testing-global-market-report
Chlamydia Infection Diagnostics Global Market Report 2025
Infectious Disease Diagnostics Testing Global Market Report 2025
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
